Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dolby Laboratories (DLB) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Dolby Laboratories (DLB) over the last 17 years, with Q4 2025 value amounting to $91.6 million.

  • Dolby Laboratories' Cost of Revenue fell 301.59% to $91.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $357.9 million, marking a year-over-year increase of 228.89%. This contributed to the annual value of $360.7 million for FY2025, which is 784.88% up from last year.
  • Per Dolby Laboratories' latest filing, its Cost of Revenue stood at $91.6 million for Q4 2025, which was down 301.59% from $90.5 million recorded in Q3 2025.
  • Dolby Laboratories' Cost of Revenue's 5-year high stood at $98.5 million during Q3 2021, with a 5-year trough of $77.5 million in Q2 2024.
  • In the last 5 years, Dolby Laboratories' Cost of Revenue had a median value of $88.8 million in 2024 and averaged $87.9 million.
  • Its Cost of Revenue has fluctuated over the past 5 years, first surged by 13187.57% in 2021, then crashed by 1540.08% in 2022.
  • Over the past 5 years, Dolby Laboratories' Cost of Revenue (Quarter) stood at $97.2 million in 2021, then decreased by 15.4% to $82.2 million in 2022, then decreased by 3.9% to $79.0 million in 2023, then rose by 19.49% to $94.4 million in 2024, then decreased by 3.02% to $91.6 million in 2025.
  • Its Cost of Revenue stands at $91.6 million for Q4 2025, versus $90.5 million for Q3 2025 and $86.2 million for Q2 2025.